SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-25-001711
Filing Date
2025-01-10
Accepted
2025-01-10 16:24:52
Documents
13
Period of Report
2025-01-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43292
  Complete submission text file 0001493152-25-001711.txt   220875

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cldi-20250110.xsd EX-101.SCH 3018
3 XBRL LABEL FILE cldi-20250110_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cldi-20250110_pre.xml EX-101.PRE 24167
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3822
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40789 | Film No.: 25523324
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)